What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Cogent Biosciences, Inc. COGT Price / sales

Discontinued — last reported Q4 '20

Price / sales at other companies

PfizerPFE

2.5×+0.2×

AmgenAMGN

5.1×+0.2×

IncyteINCY

3.5×+0.8×

Tango TherapeuticsTNGX

52.4×+48.8×

CG OncologyCGON

1,126.9×-1,693×

Relay Therapeutics, Inc.RLAY

166.6×+109×

Other financials

Income statement

See full

Operating income-$103.6M-38.3%

Net income-$97.4M-35.2%

EPS (diluted)-$0.53-1.9%

Balance sheet

See full

Cash & equivalents$241.2M+91.4%

Total debt$15.5M-9.4%

Total equity$607.7M+177%

Total assets$903.0M+218%

Cash flow

See full

Operating cash flow-$86.9M-30.6%

CapEx$449.0K-17.9%

Free cash flow-$87.3M-30.2%

Valuation

See full

Market cap$5.9B+816%

Profitability

See full

Operating margin-1,044.3%—

Net margin-950.4%—

FCF margin-184.7%—

Returns & leverage

See full

Return on equity-85.7%+1.7pp

Debt / equity0×-0.1×

Current ratio15.1×+10.0×

Where this comes from

Calculated from Cogent Biosciences, Inc.’s reported figures.

market cap/total revenue=56.9×

Based on the most recent quarter.

The official record: Cogent Biosciences, Inc.’s 10-K, filed March 15, 2022, on SEC EDGAR. View the filing →

Questions, answered.

What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.